Noriko Saito-Tarashima - Search Results

Year	Number of Results
2016	1
2017	4
2018	2
2019	1
2020	3
2021	5
2022	6
2023	3
2024	1

1

The Golgi-resident protein ACBD3 concentrates STING at ER-Golgi contact sites to drive export from the ER.

Motani K, Saito-Tarashima N, Nishino K, Yamauchi S, Minakawa N, Kosako H. Motani K, et al. Among authors: saito tarashima n. Cell Rep. 2022 Dec 20;41(12):111868. doi: 10.1016/j.celrep.2022.111868. Cell Rep. 2022. PMID: 36543137 Free article.

2

Unnatural Base Pairs for Synthetic Biology.

Saito-Tarashima N, Minakawa N. Saito-Tarashima N, et al. Chem Pharm Bull (Tokyo). 2018;66(2):132-138. doi: 10.1248/cpb.c17-00685. Chem Pharm Bull (Tokyo). 2018. PMID: 29386463 Free article. Review.

3

[Chemical Approaches for RNAi Drug Development].

Saito-Tarashima N. Saito-Tarashima N. Yakugaku Zasshi. 2020;140(10):1259-1268. doi: 10.1248/yakushi.20-00157. Yakugaku Zasshi. 2020. PMID: 32999205 Free article. Review. Japanese.

4

Synthesis of 4'-Thiomodified c-di-AMP Analogs.

Saito-Tarashima N, Kagotani Y, Inoue S, Kinoshita M, Minakawa N. Saito-Tarashima N, et al. Curr Protoc. 2023 Sep;3(9):e892. doi: 10.1002/cpz1.892. Curr Protoc. 2023. PMID: 37725690

5

Synthesis and Properties of 4'-ThioLNA/BNA.

Maeda R, Saito-Tarashima N, Wakamatsu H, Natori Y, Minakawa N, Yoshimura Y. Maeda R, et al. Among authors: saito tarashima n. Org Lett. 2021 May 21;23(10):4062-4066. doi: 10.1021/acs.orglett.1c01306. Epub 2021 May 3. Org Lett. 2021. PMID: 33938754

6

Rewriting the Central Dogma with Synthetic Genetic Polymers.

Saito-Tarashima N, Murai A, Minakawa N. Saito-Tarashima N, et al. Chem Pharm Bull (Tokyo). 2022;70(5):310-315. doi: 10.1248/cpb.c21-00960. Chem Pharm Bull (Tokyo). 2022. PMID: 35491185 Free article.

7

Cas9-mediated DNA cleavage guided by enzymatically prepared 4'-thio-modified RNA.

Saito-Tarashima N, Ueno M, Murai A, Matsuo A, Minakawa N. Saito-Tarashima N, et al. Org Biomol Chem. 2022 Jul 6;20(26):5245-5248. doi: 10.1039/d2ob00742h. Org Biomol Chem. 2022. PMID: 35726625

8

Synthesis and properties of fully-modified 4'-selenoRNA, an endonuclease-resistant RNA analog.

Ota M, Takahashi H, Nogi Y, Kagotani Y, Saito-Tarashima N, Kondo J, Minakawa N. Ota M, et al. Among authors: saito tarashima n. Bioorg Med Chem. 2022 Dec 15;76:117093. doi: 10.1016/j.bmc.2022.117093. Epub 2022 Nov 19. Bioorg Med Chem. 2022. PMID: 36434923

9

Synthesis of oligonucleotides containing 5'-homo-4'-selenouridine derivative and its increased resistance against nuclease.

Yu J, Kim JW, Chandra G, Saito-Tarashima N, Nogi Y, Ota M, Minakawa N, Jeong LS. Yu J, et al. Among authors: saito tarashima n. Bioorg Med Chem Lett. 2023 Mar 1;83:129172. doi: 10.1016/j.bmcl.2023.129172. Epub 2023 Feb 4. Bioorg Med Chem Lett. 2023. PMID: 36746352

10

Synthesis and Anti-dengue Virus Activity of 5-Ethynylimidazole-4-carboxamide (EICA) Nucleotide Prodrugs.

Nakamura M, Uemura K, Saito-Tarashima N, Sato A, Orba Y, Sawa H, Matsuda A, Maenaka K, Minakawa N. Nakamura M, et al. Among authors: saito tarashima n. Chem Pharm Bull (Tokyo). 2022 Mar 1;70(3):220-225. doi: 10.1248/cpb.c21-01038. Epub 2021 Dec 25. Chem Pharm Bull (Tokyo). 2022. PMID: 34955490 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year